HomeMNPR • NASDAQ
add
Monopar Therapeutics Inc
Previous close
$0.65
Day range
$0.64 - $0.76
Year range
$0.27 - $1.75
Market cap
12.69M USD
Avg Volume
147.85K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 1.91M | -34.27% |
Net income | -1.81M | 37.37% |
Net profit margin | — | — |
Earnings per share | -0.12 | 47.83% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 7.27M | -44.62% |
Total assets | 7.35M | -44.47% |
Total liabilities | 1.76M | -43.98% |
Total equity | 5.59M | — |
Shares outstanding | 17.45M | — |
Price to book | 1.76 | — |
Return on assets | -59.98% | — |
Return on capital | -78.37% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -1.81M | 37.37% |
Cash from operations | -1.55M | -18.75% |
Cash from investing | 2.97M | 160.39% |
Cash from financing | 334.55K | 141.14% |
Net change in cash | 1.75M | 128.56% |
Free cash flow | -938.44K | -368.29% |
About
Founded
2014
Headquarters
Website
Employees
10